Opus Genetics
IRD
14 hedge funds and large institutions have $764K invested in Opus Genetics in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0.11% more ownership
Funds ownership: 1.97% → 2.08% (+0.11%)
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
15% less capital invested
Capital invested by funds: $898K → $764K (-$134K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$58.4K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.9K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
+$17.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$545 |
| 5 |
NFG
Next Financial Group
Houston,
Texas
|
+$409 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $485K | +$58.4K | +6,001 | +11% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $158K | +$50.9K | +5,236 | +38% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $55K | – | – | – |
|
|
WS
4
Wedbush Securities
Los Angeles,
California
| $48K | +$17.8K | +1,825 | +46% |
|
5
BlackRock
New York
| $18K | – | – | – |
|
|
APA
6
American Portfolios Advisors
Holbrook,
New York
| $17 | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$3K | -272 | Closed |
|
|
BBL
8
Beck Bode LLC
Dedham,
Massachusetts
| – | +$19 | +2 | New |
|
|
NFG
9
Next Financial Group
Houston,
Texas
| – | +$409 | +42 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| – | +$545 | +56 | New |
|
IRD Hedge Fund Activity: Q3 2020 in Review
14 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q3 2020, worth a combined $764K — down 15% from $898K a quarter earlier.
Fund positioning in IRD was balanced in Q3 2020: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $58.4K. The largest seller was UBS Group, exiting entirely with an estimated $3K sold.
- 14 institutional investors held Opus Genetics (IRD) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $764K of Opus Genetics stock for Q3 2020, down 15% quarter-over-quarter.
- 3 funds opened new Opus Genetics positions in Q3 2020 and 3 closed out, a net change of 0 holders.
- The largest Opus Genetics buyer in Q3 2020 was Renaissance Technologies, an estimated $58.4K added.
- The largest Opus Genetics seller in Q3 2020 was UBS Group, an estimated $3K sold.
Based on aggregated 13F filings for Q3 2020.